Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Chong

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 1998
Glycoprotein IIb/IIIa receptor antagonists in the management of cardiovascular diseasesP H Chong
Pharmacotherapy|July 25, 2000
Periodontal disease and atherosclerotic cardiovascular disease: confounding effects or epiphenomenon?P H Chong, B Kezele
Singapore Medical Journal|April 1, 2011
The lived experience of palliative homecare nurses in SingaporeP H Chong, W H Poon
Pharmacotherapy|December 17, 1997
Atorvastatin calcium: an addition to HMG-CoA reductase inhibitorsP H Chong, J D Seeger
Drugs|August 10, 2000
Current, new and future treatments in dyslipidaemia and atherosclerosisP H Chong, B S Bachenheimer
The American Journal of Medicine|October 5, 2001
Clinically relevant differences between the statins: implications for therapeutic selectionP H Chong, J D Seeger, C Franklin
The Annals of Pharmacotherapy|November 29, 2001
Effect of acetaminophen on atherosclerosisP H Chong, B Kezele, P J Pontikes
Singapore Medical Journal|March 22, 2012
Do children die? A retrospective review of deaths in a children's hospitalP H Chong, M Y Chan, L I Yusri
BMC Palliative Care|January 5, 2018
Paediatric palliative care improves patient outcomes and reduces healthcare costs: evaluation of a home-based programP H Chong, J A De Castro Molina, K Teo, et al.
Pharmacotherapy|December 29, 2000
The low-density lipoprotein cholesterol-lowering effect of pravastatin and factors associated with achieving targeted low-density lipoprotein levels in an African-American populationP H Chong, P J Tzallas-Pontikes, J D Seeger, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 1998
Glycoprotein IIb/IIIa receptor antagonists in the management of cardiovascular diseasesP H Chong
Pharmacotherapy|July 25, 2000
Periodontal disease and atherosclerotic cardiovascular disease: confounding effects or epiphenomenon?P H Chong, B Kezele
Singapore Medical Journal|April 1, 2011
The lived experience of palliative homecare nurses in SingaporeP H Chong, W H Poon
Pharmacotherapy|December 17, 1997
Atorvastatin calcium: an addition to HMG-CoA reductase inhibitorsP H Chong, J D Seeger
Drugs|August 10, 2000
Current, new and future treatments in dyslipidaemia and atherosclerosisP H Chong, B S Bachenheimer
The American Journal of Medicine|October 5, 2001
Clinically relevant differences between the statins: implications for therapeutic selectionP H Chong, J D Seeger, C Franklin
The Annals of Pharmacotherapy|November 29, 2001
Effect of acetaminophen on atherosclerosisP H Chong, B Kezele, P J Pontikes
Singapore Medical Journal|March 22, 2012
Do children die? A retrospective review of deaths in a children's hospitalP H Chong, M Y Chan, L I Yusri
BMC Palliative Care|January 5, 2018
Paediatric palliative care improves patient outcomes and reduces healthcare costs: evaluation of a home-based programP H Chong, J A De Castro Molina, K Teo, et al.
Pharmacotherapy|December 29, 2000
The low-density lipoprotein cholesterol-lowering effect of pravastatin and factors associated with achieving targeted low-density lipoprotein levels in an African-American populationP H Chong, P J Tzallas-Pontikes, J D Seeger, et al.
Pageof 1